RANEVETMAB

UNII:	I89E5R09M4
Formula:
Preferred Substance Name:	RANEVETMAB

1632282-27-9
IMMUNOGLOBULIN G1-KAPPA, ANTI-(MUS MUSCULUS NGF (NERVE GROWTH FACTOR, NERVE GROWTH FACTOR BETA POLYPEPTIDE, NGFB, BETA-NGF)), CANINIZED MONOCLONAL ANTIBODY GAMMA1 HEAVY CHAIN (1-453) (CANINIZEDVH (RATTUS NORVEGICUS IGHV5S13*01 (71.40%) -(IGHD)-IGHJ4*01) (8.7.16) (1-122) -CANIS LUPUS FAMILIARIS IGHG1*01 (CH1 (123-219), HINGE (220-233), CH2 (234-343), CH3 (344- 451), CHS (452-453)) (123-453)), (137-213')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-217') (CANINIZEDV-KAPPA (RATTUS NORVEGICUS IGKV12S34*01 (76.80%) -IGKJ2-3*01) (6.3.9) (1'-107') -CANIS LUPUS FAMILIARIS IGKC*01 (108'-213') -4-MER (214'-217'))DIMER (224-224'':226-226'':232-232'')-TRISDISULFIDE
IMMUNOGLOBULIN, ANTI-(NERVE GROWTH FACTOR) (CANIS FAMILIARIS-RATTUS NORVEGICUS MONOCLONAL NV-01 HEAVY CHAIN), DISULFIDE WITH CANIS FAMILIARIS-RATTUS NORVEGICUS MONOCLONAL NV-01 LIGHT CHAIN, DIMER
NV-01
RANEVETMAB [INN]
RANEVETMAB [USAN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

RANEVETMAB

Synonyms and Mappings

Resources